These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 35350195)

  • 1. Humoral and cellular immune memory to four COVID-19 vaccines.
    Zhang Z; Mateus J; Coelho CH; Dan JM; Moderbacher CR; Gálvez RI; Cortes FH; Grifoni A; Tarke A; Chang J; Escarrega EA; Kim C; Goodwin B; Bloom NI; Frazier A; Weiskopf D; Sette A; Crotty S
    bioRxiv; 2022 Mar; ():. PubMed ID: 35350195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Humoral and cellular immune memory to four COVID-19 vaccines.
    Zhang Z; Mateus J; Coelho CH; Dan JM; Moderbacher CR; Gálvez RI; Cortes FH; Grifoni A; Tarke A; Chang J; Escarrega EA; Kim C; Goodwin B; Bloom NI; Frazier A; Weiskopf D; Sette A; Crotty S
    Cell; 2022 Jul; 185(14):2434-2451.e17. PubMed ID: 35764089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serious adverse reaction associated with the COVID-19 vaccines of BNT162b2, Ad26.COV2.S, and mRNA-1273: Gaining insight through the VAERS.
    Yan MM; Zhao H; Li ZR; Chow JW; Zhang Q; Qi YP; Wu SS; Zhong MK; Qiu XY
    Front Pharmacol; 2022; 13():921760. PubMed ID: 36419624
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparing the human milk antibody response after vaccination with four COVID-19 vaccines: A prospective, longitudinal cohort study in the Netherlands.
    Juncker HG; Mulleners SJ; Ruhé EJM; Coenen ERM; Bakker S; van Doesburg M; Harinck JE; Rood RD; Bouhuijs JH; Oomen M; de Groot PCJM; Pajkrt PD; Korosi A; van Goudoever PJB; van Gils MJ; van Keulen BJ
    EClinicalMedicine; 2022 May; 47():101393. PubMed ID: 35465077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study.
    Costa Clemens SA; Weckx L; Clemens R; Almeida Mendes AV; Ramos Souza A; Silveira MBV; da Guarda SNF; de Nobrega MM; de Moraes Pinto MI; Gonzalez IGS; Salvador N; Franco MM; de Avila Mendonça RN; Queiroz Oliveira IS; de Freitas Souza BS; Fraga M; Aley P; Bibi S; Cantrell L; Dejnirattisai W; Liu X; Mongkolsapaya J; Supasa P; Screaton GR; Lambe T; Voysey M; Pollard AJ;
    Lancet; 2022 Feb; 399(10324):521-529. PubMed ID: 35074136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccine-Acquired SARS-CoV-2 Immunity versus Infection-Acquired Immunity: A Comparison of Three COVID-19 Vaccines.
    Samanovic MI; Oom AL; Cornelius AR; Gray-Gaillard SL; Karmacharya T; Tuen M; Wilson JP; Tasissa MF; Goins S; Herati RS; Mulligan MJ
    Vaccines (Basel); 2022 Dec; 10(12):. PubMed ID: 36560562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of humoral and cellular response to four vaccines against COVID-19 in different age groups: A longitudinal study.
    Fedele G; Trentini F; Schiavoni I; Abrignani S; Antonelli G; Baldo V; Baldovin T; Bandera A; Bonura F; Clerici P; De Paschale M; Fortunato F; Gori A; Grifantini R; Icardi G; Lazzarotto T; Lodi V; Mastroianni CM; Orsi A; Prato R; Restivo V; Carsetti R; Piano Mortari E; Leone P; Olivetta E; Fiore S; Di Martino A; Brusaferro S; Merler S; Palamara AT; Stefanelli P
    Front Immunol; 2022; 13():1021396. PubMed ID: 36389704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NVX-CoV2373 vaccination induces functional SARS-CoV-2-specific CD4+ and CD8+ T cell responses.
    Rydyznski Moderbacher C; Kim C; Mateus J; Plested J; Zhu M; Cloney-Clark S; Weiskopf D; Sette A; Fries L; Glenn G; Crotty S
    J Clin Invest; 2022 Oct; 132(19):. PubMed ID: 35943810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 Neutralizing Antibodies: A Network Meta-Analysis across Vaccines.
    Rogliani P; Chetta A; Cazzola M; Calzetta L
    Vaccines (Basel); 2021 Mar; 9(3):. PubMed ID: 33807818
    [No Abstract]   [Full Text] [Related]  

  • 10. Homologous Ad26.COV2.S vaccination results in reduced boosting of humoral responses in hybrid immunity, but elicits antibodies of similar magnitude regardless of prior infection.
    Moyo-Gwete T; Richardson SI; Keeton R; Hermanus T; Spencer H; Manamela NP; Ayres F; Makhado Z; Motlou T; Tincho MB; Benede N; Ngomti A; Baguma R; Chauke MV; Mennen M; Adriaanse M; Skelem S; Goga A; Garrett N; Bekker LG; Gray G; Ntusi NAB; Riou C; Burgers WA; Moore PL
    medRxiv; 2023 Mar; ():. PubMed ID: 36993404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein vaccine NVX-CoV2373 elicits functional T cell immunity.
    Zhou P
    J Clin Invest; 2022 Oct; 132(19):. PubMed ID: 36189797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.
    Li Z; Xiang T; Liang B; Deng H; Wang H; Feng X; Quan X; Wang X; Li S; Lu S; Yang X; Wang B; Zelinskyy G; Trilling M; Sutter K; Lu M; Dittmer U; Yang D; Zheng X; Liu J
    Front Immunol; 2021; 12():802858. PubMed ID: 35003131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infection pre-Ad26.COV2.S-vaccination primes greater class switching and reduced CXCR5 expression by SARS-CoV-2-specific memory B cells.
    Krause RGE; Moyo-Gwete T; Richardson SI; Makhado Z; Manamela NP; Hermanus T; Mkhize NN; Keeton R; Benede N; Mennen M; Skelem S; Karim F; Khan K; Riou C; Ntusi NAB; Goga A; Gray G; Hanekom W; Garrett N; Bekker LG; Groll A; Sigal A; Moore PL; Burgers WA; Leslie A
    NPJ Vaccines; 2023 Aug; 8(1):119. PubMed ID: 37573434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics and Persistence of the Cellular and Humoral Immune Responses to BNT162b2 mRNA Vaccine in SARS-CoV-2-Naive and -Experienced Subjects: Impact of Booster Dose and Breakthrough Infections.
    Desmecht S; Tashkeev A; El Moussaoui M; Marechal N; Perée H; Tokunaga Y; Fombellida-Lopez C; Polese B; Legrand C; Wéry M; Mni M; Fouillien N; Toussaint F; Gillet L; Bureau F; Lutteri L; Hayette MP; Moutschen M; Meuris C; Vermeersch P; Desmecht D; Rahmouni S; Darcis G
    Front Immunol; 2022; 13():863554. PubMed ID: 35711445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the Immune Responses to COVID-19 Vaccines in Bangladeshi Population.
    Sarker P; Akhtar E; Kuddusi RU; Alam MM; Haq MA; Hosen MB; Chanda BC; Haque F; Alam M; Razzaque A; Rahman M; Ahmed F; Kibria MG; Islam MZ; Ahmed S; Raqib R
    Vaccines (Basel); 2022 Sep; 10(9):. PubMed ID: 36146576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccines elicit highly conserved cellular immunity to SARS-CoV-2 Omicron.
    Liu J; Chandrashekar A; Sellers D; Barrett J; Jacob-Dolan C; Lifton M; McMahan K; Sciacca M; VanWyk H; Wu C; Yu J; Collier AY; Barouch DH
    Nature; 2022 Mar; 603(7901):493-496. PubMed ID: 35102312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of human immune responses following SARS-CoV-2 vaccination with BNT162b2, mRNA-1273, or Ad26.COV2.S.
    Barbeau DJ; Martin JM; Carney E; Dougherty E; Doyle JD; Dermody TS; Hoberman A; Williams JV; Michaels MG; Alcorn JF; Paul Duprex W; McElroy AK
    NPJ Vaccines; 2022 Jul; 7(1):77. PubMed ID: 35794181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccines Elicit Highly Cross-Reactive Cellular Immunity to the SARS-CoV-2 Omicron Variant.
    Liu J; Chandrashekar A; Sellers D; Barrett J; Lifton M; McMahan K; Sciacca M; VanWyk H; Wu C; Yu J; Collier AY; Barouch DH
    medRxiv; 2022 Jan; ():. PubMed ID: 35018387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Perception and Attitudes toward COVID-19 Vaccines: A Cross-Sectional Study in Poland.
    Rzymski P; Zeyland J; Poniedziałek B; Małecka I; Wysocki J
    Vaccines (Basel); 2021 Apr; 9(4):. PubMed ID: 33919672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular and humoral functional responses after BNT162b2 mRNA vaccination differ longitudinally between naive and subjects recovered from COVID-19.
    Lozano-Rodríguez R; Valentín-Quiroga J; Avendaño-Ortiz J; Martín-Quirós A; Pascual-Iglesias A; Terrón-Arcos V; Montalbán-Hernández K; Casalvilla-Dueñas JC; Bergón-Gutiérrez M; Alcamí J; García-Pérez J; Cascajero A; García-Garrido MÁ; Balzo-Castillo ÁD; Peinado M; Gómez L; Llorente-Fernández I; Martín-Miguel G; Herrero-Benito C; Benito JM; Rallón N; Vela-Olmo C; López-Morejón L; Cubillos-Zapata C; Aguirre LA; Fresno CD; López-Collazo E
    Cell Rep; 2022 Jan; 38(2):110235. PubMed ID: 34986327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.